198 related articles for article (PubMed ID: 26099723)
1. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.
Khedr NF; Khalil RM
Tumour Biol; 2015 Dec; 36(12):9267-75. PubMed ID: 26099723
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
[TBL] [Abstract][Full Text] [Related]
3. Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.
El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
Tumour Biol; 2017 May; 39(5):1010428317692235. PubMed ID: 28459206
[TBL] [Abstract][Full Text] [Related]
4. Amelioration effect of Egyptian sweet orange hesperidin on Ehrlich ascites carcinoma (EAC) bearing mice.
Donia TIK; Gerges MN; Mohamed TM
Chem Biol Interact; 2018 Apr; 285():76-84. PubMed ID: 29481770
[TBL] [Abstract][Full Text] [Related]
5. Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms.
El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
Eur J Nutr; 2018 Apr; 57(3):981-989. PubMed ID: 28229277
[TBL] [Abstract][Full Text] [Related]
6. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
El-Sisi AE; Sokkar SS; Ibrahim HA; Hamed MF; Abu-Risha SE
Fundam Clin Pharmacol; 2020 Aug; 34(4):458-475. PubMed ID: 32080901
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of hesperidin through attenuation of Ki67 expression against DMBA-induced breast cancer in female rats.
Patel P; Shah J
Life Sci; 2021 Nov; 285():119957. PubMed ID: 34530017
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer and cardioprotective effects of indol-3-carbinol in doxorubicin-treated mice.
Adwas AA; Elkhoely AA; Kabel AM; Abdel-Rahman MN; Eissa AA
J Infect Chemother; 2016 Jan; 22(1):36-43. PubMed ID: 26603425
[TBL] [Abstract][Full Text] [Related]
9. Synergistic efficacy of γ-radiation together with gallium trichloride and/or doxorubicin against Ehrlich carcinoma in female mice.
Kandil E; Aziz NA
Tumour Biol; 2016 Feb; 37(2):1825-34. PubMed ID: 26318299
[TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin and methotrexate on solid Ehrlich tumor.
Kabel AM; Abdel-Rahman MN; El-Sisi Ael-D; Haleem MS; Ezzat NM; El Rashidy MA
Eur J Pharmacol; 2013 Aug; 713(1-3):47-53. PubMed ID: 23669249
[TBL] [Abstract][Full Text] [Related]
11. Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice.
Zidan A; El Saadany AA; El Maghraby GM; Abdin AA; Hedya SE
Toxicol Appl Pharmacol; 2023 Apr; 465():116448. PubMed ID: 36921847
[TBL] [Abstract][Full Text] [Related]
12. Hesperetin may alleviate the development of doxorubicin-induced pulmonary toxicity by decreasing oxidative stress and apoptosis in male rats.
Erdem Guzel E; Kaya Tektemur N
Tissue Cell; 2021 Dec; 73():101667. PubMed ID: 34653889
[TBL] [Abstract][Full Text] [Related]
13. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
[TBL] [Abstract][Full Text] [Related]
14. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
15. Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms.
Gaballah HH; Gaber RA; Mohamed DA
Toxicol Appl Pharmacol; 2017 Feb; 316():27-35. PubMed ID: 28025107
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
[TBL] [Abstract][Full Text] [Related]
17. LQFM030 reduced Ehrlich ascites tumor cell proliferation and VEGF levels.
da Mota MF; de Carvalho FS; de Ávila RI; de Ávila PHM; Cortez AP; Menegatti R; Sabino JR; Dos Santos TRM; Gomes SA; da Cunha LC; Valadares MC
Life Sci; 2018 May; 201():1-8. PubMed ID: 29278686
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma.
Noaman E; Badr El-Din NK; Bibars MA; Abou Mossallam AA; Ghoneum M
Cancer Lett; 2008 Sep; 268(2):348-59. PubMed ID: 18554778
[TBL] [Abstract][Full Text] [Related]
19. Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice.
Yalçin E; Oruç E; Cavuşoğlu K; Yapar K
J Med Food; 2010 Aug; 13(4):917-25. PubMed ID: 20553142
[TBL] [Abstract][Full Text] [Related]
20. In vivo effect of oracin on doxorubicin reduction, biodistribution and efficacy in Ehrlich tumor bearing mice.
Hanušová V; Tomšík P; Kriesfalusyová L; Pakostová A; Boušová I; Skálová L
Pharmacol Rep; 2013; 65(2):445-52. PubMed ID: 23744429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
